Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant

Publisher： John Wiley & Sons Inc

E-ISSN： 1096-8652|91|10|E442-E447

ISSN： 0361-8609

Source： AMERICAN JOURNAL OF HEMATOLOGY, Vol.91, Iss.10, 2016-10, pp. : E442-E447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant

By  

CANCER, Vol. 119, Iss. 23, 2013-12 ,pp. : 4188-4195

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence of infection according to intravenous immunoglobulin use in autologous hematopoietic stem cell transplant recipients with multiple myeloma

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 1398-2273, Iss. 5, 2015-10 ,pp. : 679-687

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence of infection according to intravenous immunoglobulin use in autologous hematopoietic stem cell transplant recipients with multiple myeloma

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 5, 2015-10 ,pp. : 679-687

John Wiley & Sons Inc

Access to resources Recommend Favorite

The roles of consolidation and maintenance therapy with novel agents after autologous stem cell transplantation in patients with multiple myeloma

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 2015-02 ,pp. : 109-114

John Wiley & Sons Inc

Access to resources Recommend Favorite

Poor peripheral blood stem cell mobilization affects long‐term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation

By  

JOURNAL OF CLINICAL APHERESIS, Vol. 33, Iss. 1, 2018-02 ,pp. : 29-37

John Wiley & Sons Inc

Access to resources Recommend Favorite